Spadoni G - Search Results

1

NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.

Fotio Y, Mabou Tagne A, Squire E, Lee HL, Phillips CM, Chang K, Ahmed F, Greenberg AS, Villalta SA, Scarfone VM, Spadoni G, Mor M, Piomelli D. Fotio Y, et al. Among authors: spadoni g. Nat Commun. 2024 Feb 24;15(1):1705. doi: 10.1038/s41467-024-46139-5. Nat Commun. 2024. PMID: 38402219 Free PMC article.

2

Structure-affinity relationships of indole-based melatonin analogs.

Spadoni G, Mor M, Tarzia G. Spadoni G, et al. Biol Signals Recept. 1999 Jan-Apr;8(1-2):15-23. doi: 10.1159/000014564. Biol Signals Recept. 1999. PMID: 10085458 Review.

3

Melatonin.

Mor M, Plazzi PV, Spadoni G, Tarzia G. Mor M, et al. Among authors: spadoni g. Curr Med Chem. 1999 Jun;6(6):501-18. Curr Med Chem. 1999. PMID: 10213796 Review.

4

Design and synthesis of melatonin receptors agonists and antagonists.

Tarzia G, Diamantini G, Mor M, Spadoni G. Tarzia G, et al. Among authors: spadoni g. Farmaco. 2000 Mar;55(3):184-7. doi: 10.1016/s0014-827x(00)00017-3. Farmaco. 2000. PMID: 10919077 Review.

5

Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists.

Tarzia G, Duranti A, Tontini A, Spadoni G, Mor M, Rivara S, Vincenzo Plazzi P, Kathuria S, Piomelli D. Tarzia G, et al. Among authors: spadoni g. Bioorg Med Chem. 2003 Sep 1;11(18):3965-73. doi: 10.1016/s0968-0896(03)00413-9. Bioorg Med Chem. 2003. PMID: 12927857 Free article.

6

Strategies leading to MT2 selective melatonin receptor antagonists.

Spadoni G, Bedini A, Piersanti G, Mor M, Rivara S, Tarzia G. Spadoni G, et al. Adv Exp Med Biol. 2003;527:577-85. doi: 10.1007/978-1-4615-0135-0_66. Adv Exp Med Biol. 2003. PMID: 15206776

7

Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.

Rivara S, Lorenzi S, Mor M, Plazzi PV, Spadoni G, Bedini A, Tarzia G. Rivara S, et al. Among authors: spadoni g. J Med Chem. 2005 Jun 16;48(12):4049-60. doi: 10.1021/jm048956y. J Med Chem. 2005. PMID: 15943478

8

Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.

Rivara S, Diamantini G, Di Giacomo B, Lamba D, Gatti G, Lucini V, Pannacci M, Mor M, Spadoni G, Tarzia G. Rivara S, et al. Among authors: spadoni g. Bioorg Med Chem. 2006 May 15;14(10):3383-91. doi: 10.1016/j.bmc.2005.12.053. Epub 2006 Jan 20. Bioorg Med Chem. 2006. PMID: 16431121

9

Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.

Mor M, Rivara S, Lodola A, Lorenzi S, Bordi F, Plazzi PV, Spadoni G, Bedini A, Duranti A, Tontini A, Tarzia G. Mor M, et al. Among authors: spadoni g. Chem Biodivers. 2005 Nov;2(11):1438-51. doi: 10.1002/cbdv.200590117. Chem Biodivers. 2005. PMID: 17191945

10

N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.

Rivara S, Lodola A, Mor M, Bedini A, Spadoni G, Lucini V, Pannacci M, Fraschini F, Scaglione F, Sanchez RO, Gobbi G, Tarzia G. Rivara S, et al. Among authors: spadoni g. J Med Chem. 2007 Dec 27;50(26):6618-26. doi: 10.1021/jm700957j. Epub 2007 Dec 6. J Med Chem. 2007. PMID: 18052314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters